1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key benefits for the stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. AI IN GENOMICS MARKET BY OFFERING
5.1. Introduction
5.2. Software tools
5.3. Services
6. AI IN GENOMICS MARKET BY APPLICATION
6.1. Introduction
6.2. Precision medicine
6.3. Diagnosis and prognosis
6.4. Drug discovery and development
6.5. Agriculture and animal breeding
6.6. Others
7. AI IN GENOMICS MARKET BY END-USER
7.1. Introduction
7.2. Pharmaceutical and biotechnology companies
7.3. Academic and research institutes
7.4. Hospitals and diagnostic centers
7.5. Others
8. AI IN GENOMICS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Offering
8.2.2. By Application
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Offering
8.3.2. By Application
8.3.3. By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Offering
8.4.2. By Application
8.4.3. By End-User
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Offering
8.5.2. By Application
8.5.3. By End-User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. Israel
8.5.4.3. UAE
8.5.4.4. Others
8.6. Asia Pacific
8.6.1. By Offering
8.6.2. By Application
8.6.3. By End-User
8.6.4. By Country
8.6.4.1. China
8.6.4.2. Japan
8.6.4.3. India
8.6.4.4. South Korea
8.6.4.5. Australia
8.6.4.6. Vietnam
8.6.4.7. Indonesia
8.6.4.8. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. IBM
10.2. Sophia Genetics SA
10.3. QIAGEN N.V.
10.4. Fabric Genomics, Inc.
10.5. Congenica Ltd.
10.6. Illumina, Inc.
10.7. Freenome Holdings, Inc.
10.8. Data4cure, Inc.
10.9. Tempus Labs, Inc.
10.10. NVIDIA Corporation